Matching patients to clinical trials with large language models

Patient recruitment is challenging for clinical trials. We introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models. TrialGPT comprises three modules: it first performs large-scale filtering to retrieve candidate trials (TrialGPT-Retrieval); then predicts criterion-level patient eligibility (TrialGPT-Matching); and finally generates trial-level scores (TrialGPT-Ranking). We evaluate TrialGPT on three cohorts of 183 synthetic patients with over 75,000 trial annotations. TrialGPT-Retrieval can recall over 90% of relevant trials using less than 6% of the initial collection. Manual evaluations on 1015 patient-criterion pairs show that TrialGPT-Matching achieves an accuracy of 87.3% with faithful explanations, close to the expert performance. The TrialGPT-Ranking scores are highly correlated with human judgments and outperform the best-competing models by 43.8% in ranking and excluding trials. Furthermore, our user study reveals that TrialGPT can reduce the screening time by 42.6% in patient recruitment. Overall, these results have demonstrated promising opportunities for patient-to-trial matching with TrialGPT.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-11-18
DOI
https://doi.org/10.1038/s41467-024-53081-z
Citations
170
Primary Topic
Topic Modeling
Type
article
Field-Weighted Citation Impact
58.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Matching patients to clinical trials with large language models

Changlin Gong, Dara Bracken‐Clarke, Fangyuan Chen, Charalampos S. Floudas et al.
170 citations
Nature Communications
Topic Modeling
58.71
article

Matching patients to clinical trials with large language models

Changlin Gong, Dara Bracken‐Clarke, Fangyuan Chen, Charalampos S. Floudas, Zifeng Wang, Elisabetta Xue, Zhiyong Lu, Jimeng Sun, Qiao Jin, Yifan Yang
article en
170 citations

Abstract

Patient recruitment is challenging for clinical trials. We introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models. TrialGPT comprises three modules: it first performs large-scale filtering to retrieve candidate trials (TrialGPT-Retrieval); then predicts criterion-level patient eligibility (TrialGPT-Matching); and finally generates trial-level scores (TrialGPT-Ranking). We evaluate TrialGPT on three cohorts of 183 synthetic patients with over 75,000 trial annotations. TrialGPT-Retrieval can recall over 90% of relevant trials using less than 6% of the initial collection. Manual evaluations on 1015 patient-criterion pairs show that TrialGPT-Matching achieves an accuracy of 87.3% with faithful explanations, close to the expert performance. The TrialGPT-Ranking scores are highly correlated with human judgments and outperform the best-competing models by 43.8% in ranking and excluding trials. Furthermore, our user study reveals that TrialGPT can reduce the screening time by 42.6% in patient recruitment. Overall, these results have demonstrated promising opportunities for patient-to-trial matching with TrialGPT.

Nature CommunicationsVol. 15(1)
National Institutes of Health (US), Albert Einstein College of Medicine (US), University of Illinois Urbana-Champaign (US), University of Pittsburgh (US), National Center for Biotechnology Information (US), National Cancer Institute (US), Center for Cancer Research (US), University of Maryland, College Park (US)
National Institutes of Health, U.S. National Library of Medicine
Quality Education
Openalex Percentile: Top 0%
Topic Modeling
58.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.